ANI shareholders approve doubling authorized common shares to 66M and equity plan amendments

ANI PHARMACEUTICALS INC

Stockholders approved Certificate of Amendment raising authorized common shares from 33,333,334 to 66,000,000; effective May 22, 2025.
Amended 2022 Stock Incentive Plan approved (15,056,885 for, 1,202,893 against, 10,460 abstain).
Amended 2016 Employee Stock Purchase Plan approved (16,173,976 for, 89,098 against, 7,164 abstain).
Eight director nominees elected; EisnerAmper LLP ratified as auditor; say-on-pay advisory approved.

item 5.02item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.